CDMO241115P20000
- 0.00
- 0.000.00%
Avid Bioservices Newsroom
Shareholder Alert: Ademi LLP Investigates Whether Avid Bioservices, Inc. Is Obtaining a Fair Price for Its Public Shareholders
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Avid Bioservices, Inc.
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Craig-Hallum Sticks to Its Buy Rating for Avid Bioservices (CDMO)
Avid Biosciences Shares Are Trading Higher After the Company Announced It Agreed to Be Acquired by GHO Capital Partners and Ampersand in a $1.1 Billion Transaction. Also, RBC Capital Raised Its Price Target on the Stock From $12 to $12.5.
GHO and Ampersand Capital to Acquire Avid Bioservices
Avid Bioservices to Be Acquired in $1.1 Billion Deal
Here's Why Avid Bioservices (NASDAQ:CDMO) Can Afford Some Debt
RBC Capital Downgrades Avid Bioservices(CDMO.US) to Hold Rating, Raises Target Price to $12.5
William Blair Reiterates Market Perform on Avid Bioservices
Avid Bioservices Analyst Ratings
Express News | Avid Bioservices Inc : RBC Cuts to Sector Perform From Outperform
Hershey, Upwork And 3 Stocks To Watch Heading Into Thursday
Trading Halt: Halt Status Updated at 6:30:00 PM ET: Quotation Resumption: News and Resumption Times
Avid Bioservices Purchase Price Represents 13.8% Premium to Closing Share Price on Nov. 6 >CDMO
Express News | Avid Bioservices Inc: Upon Completion Avid Common Stock Will No Longer Be Listed on Any Public Stock Exchange
Express News | Avid Bioservices Inc: Proposed Deal for $12.50 per Share
Avid Bioservices to Be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
Express News | Avid Bioservices to Be Acquired by Gho Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
Press Release: Avid Bioservices to Be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction